Article Text

Download PDFPDF
CASE REPORT
Bitter experience with liquorice sweetening agent resulting in apparent mineralocorticoid excess with periodic paralysis
  1. Roshna Ramchandran,
  2. Shivendra Verma,
  3. Riddhi Dasgupta,
  4. Nihal Thomas
  1. Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, Tamil Nadu, India
  1. Correspondence to Dr Riddhi Dasgupta, riddhi_dg{at}rediffmail.com

Summary

Chronic liquorice ingestion is a rare cause of secondary hypertension and hypokalaemia with periodic paralysis. We report the case of a middle-aged Indian man who presented with hypertension and hypokalaemic alkalosis with recurrent bouts of periodic paralysis. Biochemical investigations revealed suppressed plasma renin and aldosterone concentrations with normal cortisol concentration. A detailed history revealed that he was addicted for the last 5 years to a form of chewing tobacco mixed with herbal preparations as a sweetening agent which on analysis revealed active principles of glycyrrhizin using the thin liquid chromatography method. The hypokalaemia resolved and hypertension control improved significantly after discontinuing liquorice consumption, and the patient was asymptomatic at 1-year follow-up. Long-term liquorice ingestion should be kept in mind as a reversible cause of hypokalaemic periodic paralysis, with a meticulous history and biochemical evaluation helping in identifying this recognisable and curable medical disorder.

  • adrenal disorders
  • metabolic disorders
  • fluid electrolyte and acid-base disturbances

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors RR and SV: planning, drafting, conception and design of the manuscript. RD and NT: acquisition of the data and contributed to the development and design. All authors contributed to the manuscript and declare no conflict of interest.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.